The next generation mass spectrometer market is projected to grow from USD 2.3 billion in 2025 to USD 4.7 billion by 2035, at a CAGR of 7.2%. Pharmaceuticals will dominate with a 31.0% market share, while research centers will lead the end user segment with a 37.0% share.